Hydrazine

Hydrazine

SCHEMBL6187793

CS(=O)(=O)c1cccnc1.NN

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NAPRT Q6XQN6 1/20 0.59
PTGS2 P35354 6/20 0.53
SLC1A3 P43003 1/20 0.46
SLC1A2 P43004 1/20 0.46
SLC1A1 P43005 1/20 0.46
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA9 Q16790 1/20 0.46
PTGS1 P23219 3/20 0.45
LMNA P02545 1/20 0.44
POLB P06746 1/20 0.44
KEAP1 Q14145 1/20 0.43
NFE2L2 Q16236 1/20 0.43
MAPT P10636 1/20 0.41
LOX P28300 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL355006 0.96 NAPRT (0.63) NAPRTPTGS2CA12CA1CA2
SCHEMBL29497666 0.96 NAPRT (0.63) NAPRTPTGS2CA12CA1CA2
Hydrochloric Acid SCHEMBL27577370 0.94 NAPRT (0.61) NAPRTPTGS2CA12CA1CA2
Acetic Acid SCHEMBL27925923 0.86 NAPRT (0.58) NAPRTPTGS2SLC1A3SLC1A2SLC1A1
Phenol SCHEMBL27849941 0.83 NAPRT (0.55) NAPRTPTGS2SLC1A3SLC1A2SLC1A1
SCHEMBL18838452 0.80 NAPRT (0.55) NAPRTPTGS2SLC1A3SLC1A2SLC1A1
SCHEMBL15695400 0.79 NAPRT (0.59) NAPRTPTGS2SLC1A3SLC1A2SLC1A1
SCHEMBL393736 0.78 CA2 (0.63) NAPRTSLC1A3SLC1A2SLC1A1CA12
SCHEMBL29614165 0.78 CA2 (0.63) NAPRTSLC1A3SLC1A2SLC1A1CA12
SCHEMBL24995343 0.78 NAPRT (0.56) NAPRTPTGS2CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1273582-B1 Heterocyclo-alkylsulfonyl pyrazoles as anti-inflammatory/analgesic agents PFIZER PROD INC (US) 2005-06-29 EP disclosed
US-6900230-B2 Heterocyclo-alkylsulfonyl pyrazoles as anti-inflammatory/analgesic agents PFIZER INC. (US) 2005-05-31 US disclosed
US-20030119836-A1 Heterocyclo-alkylsulfonyl pyrazoles as anti-inflammatory/analgesic agents SAKYA SUBAS M (US) 2003-06-26 US disclosed
EP-1273582-A1 Heterocyclo-alkylsulfonyl pyrazoles as anti-inflammatory/analgesic agents Pfizer Products Inc. (US) 2003-01-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030119836-A1 Heterocyclo-alkylsulfonyl pyrazoles as anti-inflammatory/analgesic agents PTGS1, SULT2A1, AHR NAPRT 1738/4885PTGS2 37/4885SLC1A3 2611/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.